PerClot Standard - Surgical plant polysaccharide haemostatic agent

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Disponible depuis:

Baxter Healthcare Pty Ltd

classe:

Class III

Fabriqué par:

Starch Medical Inc 2150 Ringwood Avenue, San Jose, CA, 95131 United States Of America

Domaine thérapeutique:

38771 - Surgical plant polysaccharide haemostatic agent

indications thérapeutiques:

The device is composed of Absorbale Modified Particles (AMP) made from starch and delivery applicators. When AMP particles contact blood, the hydrophilic and adhesive properties can concentrate blood,resulting in instant clotting. In the meantime the "AMP-blood coagulation matrix" has strong adhesive characteristics which can adhere and seal the wound tissue and stop bleeding,resulting in hemostasis Indicated for use in surgical procedures (except neurological and ophthalmic) or injuries as an adjunct haemostat when control of bleeding from capillary, venous, or arteriolar vessels by pressure, ligature, and other conventional means is either ineffective or impractical.

Statut de autorisation:

A

Date de l'autorisation:

2009-07-01

Résumé des caractéristiques du produit

STERILIZING METHOD & EXPIRATION DATE
22
PerClot
®
is available in 1g, 3g and 5g configurations.
PerClot
®
applicators are available in the following lengths: 90mm, 200mm and
380mm.
25
UN DIAGRAMA ESQUEMÁTICO DE PERCLOT
® LAPAROSCOPIC
62